Loading the company…
Loading the company…
Families: Peripheral arterial intervention, Dialysis access.
All companies · Product and company coverage
In the last ten years FDA made 15 decisions for Veryan Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2024 (5). The latest was on 2026-02-19.
| Family | Decisions on record |
|---|---|
| Peripheral arterial intervention | 15 |
| Dialysis access | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-02-19 | PMA | P180003-S014 | BioMimics 3D® Vascular Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-01-07 | PMA | P180003-S013 | BioMimics 3D® Vascular Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-06-26 | PMA | P180003-S012 | BioMimics 3D Vascular Stent System · Change Design/Components/Specifications/Material |
| 2024-11-14 | PMA | P180003-S011 | BioMimics 3D® Vascular Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
In 2025, Veryan Medical reported engagement with 153 surgeons and other clinicians in the states MedaRep covers, worth $471K in consulting, speaking, meals and travel for its device products, the most in Florida ($375K to 7). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($375K, 7 engaged), Ohio ($82K, 2 engaged), Texas ($3,854, 27 engaged), Connecticut ($2,783, 6 engaged), Massachusetts ($2,192, 32 engaged).
| 2024-09-20 | PMA | P180003-S010 | BioMimics 3D Vascular Stent System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Veryan Medical.